Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Omega Healthcare ( (OHI) ) is now available.
At Omega Healthcare‘s Annual Meeting, shareholders voted on several key proposals, including the election of directors, ratification of Ernst & Young LLP as the independent auditor for fiscal year 2025, approval of executive compensation on an advisory basis, and an amendment to increase the number of authorized shares of common stock. All proposals were approved, and changes to the board’s committee memberships were announced, with Stephen D. Plavin being appointed to the Investment Committee.
The most recent analyst rating on (OHI) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Omega Healthcare stock, see the OHI Stock Forecast page.
Spark’s Take on OHI Stock
According to Spark, TipRanks’ AI Analyst, OHI is a Outperform.
Omega Healthcare’s overall stock score is bolstered by strong financial performance and positive earnings call outcomes, though tempered by valuation concerns and neutral technical signals. The notable dividend yield provides an incentive for investors.
To see Spark’s full report on OHI stock, click here.
More about Omega Healthcare
Average Trading Volume: 2,629,807
Technical Sentiment Signal: Strong Buy
Current Market Cap: $10.83B
For a thorough assessment of OHI stock, go to TipRanks’ Stock Analysis page.